Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative systemic prednisolone after nasal polypectomy in chronic rhinosinusitis with nasal polyps
IRCT20190325043107N89Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisolone in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Nasal Polyp Score. Started Oct 2026; status: recruiting.
02
Drugs
prednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20190325043107N89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N89.